within Pharmacolibrary.Drugs.ATC.S;

model S01AE05_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00014166666666666668,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.074,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.047,
    k12             = 12.7,
    k21             = 12.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AE05_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Levofloxacin is a broad-spectrum fluoroquinolone antibiotic used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin infections. It is an approved medication and is widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Setiawan, E, et al., &amp; Roberts, JA (2022). Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients. <i>Scientific reports</i> 12(1) 8930–None. DOI:<a href=\"https://doi.org/10.1038/s41598-022-12627-1\">10.1038/s41598-022-12627-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35624222/\">https://pubmed.ncbi.nlm.nih.gov/35624222</a></p></li><li><p>Landoni, MF, &amp; Albarellos, GA (2019). Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 42(2) 171–178. DOI:<a href=\"https://doi.org/10.1111/jvp.12726\">10.1111/jvp.12726</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30302775/\">https://pubmed.ncbi.nlm.nih.gov/30302775</a></p></li><li><p>Urzúa, N, et al., &amp; Errecalde, C (2020). Pharmacokinetics of levofloxacin after single intravenous and oral administration, and its interaction with sucralfate in mixed-breed dogs. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 50(12) 1490–1493. DOI:<a href=\"https://doi.org/10.1080/00498254.2020.1793031\">10.1080/00498254.2020.1793031</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32628058/\">https://pubmed.ncbi.nlm.nih.gov/32628058</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AE05_1;
